> top > docs > DevicePMAs@therightstef:P160053_S000

DevicePMAs@therightstef:P160053_S000 JSONTXT

Approval for the MagtraceTM and Sentimag Magnetic Localization System. The MagtraceTM and Sentimag Magnetic Localization System is indicated to assist in localizing lymph nodes draining a tumor site, as part of a sentinel lymph node biopsy procedure, in patients with breast cancer undergoing a mastectomy. MagtraceTM is intended and calibrated for use ONLY with the Sentimag system.

projects that include this document

Unselected / annnotation Selected / annnotation